Frankly, I don't care what Amrn's sentiments are on Vascepa 2.0. I care about BP's sentiment about a "FRESH" IP, and how that IP changes the entire equation of the domestic market. MK came from BP. You think he doesn't know that Amrn's future was never GIA, and still isn't today? It's an office with executives. BP knows how to take things to the next level.